MedTrace Logo

SocIal ROBOTics for Active and Healthy Ageing

NCT05005208 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-10-23

No results posted yet for this study

Summary

The study was designed to test the acceptability of the Si-Robotics system in a group of 20 subjects with Parkinson's Disease at an early stage, during a rehabilitation treatment based on Irish dancing. Assessments will be performed at the baseline and at the end of the treatment.

Conditions

  • Parkinson Disease
  • Aging

Interventions

OTHER

rehabilitation program with the support of the technological platform SI-ROBOTICS

A 16-treatment session will be conducted, divided into 2 training sessions per week, for 8 weeks. The therapy sessions last 60 minutes; each session will involve 2 patients at time. Cardiac and respiratory activity monitoring is planned during robotic treatments in order to detect the heart rate during physical activity. Individual participants must complete at least 80% of the sessions. Recovery of 2 sessions will be possible. Each session involves the following activities: * Breathing, relaxation and postural harmonization exercises; * Active mobility and stretching exercises; * Irish dance with the SI-ROBOTICS system; * Relaxation exercises.

Sponsors & Collaborators

  • Ministero dell'Università e della Ricerca, Italia

    collaborator UNKNOWN

  • Istituto Nazionale di Ricovero e Cura per Anziani

    lead OTHER

Principal Investigators

  • Giovanni Riccardi, MD · IRCCS-INRCA

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-19
Primary Completion
2024-03-29
Completion
2024-03-29

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05005208 on ClinicalTrials.gov